Approval · Notice of Compliance 1459 · 2000
NAROPIN: Notice of Compliance 1459
Issued February 15, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1459
- Date
- February 15, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Local anesthetic
Products in this notice
Medicinal ingredients
- ROPIVACAINE HYDROCHLORIDE 2 MG per ML
- ROPIVACAINE HYDROCHLORIDE 5 MG per ML
- ROPIVACAINE HYDROCHLORIDE 7.5 MG per ML
- ROPIVACAINE HYDROCHLORIDE 10 MG per ML